Press Releases

BD, a leading global medical technology company announced the formation of a strategic, public-private partnership with the Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Health and Human Services Office of the Assistant Secretary for Preparedness...

The Alzheimer's Clinical Trials Consortium , Eisai Co., Ltd and Biogen Inc announced that a new phase III clinical study (AHEAD 3-45) of BAN2401, an anti-amyloid beta (Aß) protofibril antibody, has been initiated in the United States of America...

Cipla Limited announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Icatibant Injectable 30mg/3mL from the United States Food and Drug Administration (US FDA). Cipla’s Icatibant Injectable Pre-Filled Syringe 30mg/3mL is AP-rated generic version...

Merck, a leading science and technology company, opened its M LabTM Collaboration Center in Shanghai, the company’s largest of nine centers worldwide. “With the booming pharmaceutical industry in Asia and greater emphasis on novel drug therapies, we see an increase...

Samsung Biologics and ImmuneOncia Therapeutics held a signing ceremony for a contract to develop and manufacture five candidate molecules, expanding upon the two companies existing CDO partnership first established in 2018. “As we already have a track record of successful...

Powder containment and sterile transfer solutions experts, ChargePoint Technology, announced that it has entered into a collaboration with STERIS, a leading provider of infection prevention and other procedural products and services, to offer a unique and integrated solution for...

Biocon Ltd., an innovation-led global biopharmaceuticals company, announced that it has received the Drugs Controller General of India’s (DCGI) approval to market Itolizumab (ALZUMAb®) Injection 25mg/5mL solution for emergency use in India for the treatment of cytokine release syndrome...